Valuation : Ovation Science Inc.

Market Cap 1.15M 833K 719K 677K 617K 78.71M 1.16M 8.02M 3.11M 40.24M 3.13M 3.06M 132M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 986K 850K 801K 730K 93.1M 1.37M 9.48M 3.68M 47.6M 3.7M 3.62M 156M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day+50.00%
3 months+100.00%
6 months-14.29%
Current year-25.00%
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.14
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 86 2018-02-01
Date Insider Type Main position Quantity % Market Cap. Importance
4/7/25 Buy

Director

100,000 0.2642%
1/31/25 Other

Director

0 0%
1/31/25 Buy

Director

100,000 0.2642%
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%-.--%-40.00%+50.00% 833K
-1.26%-1.22%-4.87%-6.31% 238B
-1.36%-4.36%+17.75% - 47.63B
-3.12%-5.20%+90.45% - 11.55B
-1.69%-7.43%+41.72%-42.50% 8.77B
-2.73%-0.84%+20.49%+6.75% 6.47B
+1.72%+0.36%-14.52%-21.62% 6.34B
-0.56%-0.18%+2.22%-17.25% 3.73B
+0.29%-0.73%-24.66%-43.48% 3.66B
-0.07%0.00%-4.43%-41.34% 2.85B
Average +4.12%-1.28%+8.42%-14.47% 32.86B
Weighted average by Cap. -1.29%-1.13%+3.18%-8.56%

Financials

2024 2025
Net sales 113K 81.8K 70.57K 66.48K 60.57K 7.73M 114K 787K 305K 3.95M 307K 300K 12.98M 67.89K 49.05K 42.32K 39.86K 36.32K 4.63M 68.4K 472K 183K 2.37M 184K 180K 7.78M
Net income -456K -330K -284K -268K -244K -31.14M -460K -3.17M -1.23M -15.92M -1.24M -1.21M -52.3M -631K -456K -393K -371K -338K -43.09M -636K -4.39M -1.7M -22.03M -1.71M -1.68M -72.36M
Net Debt 265K 192K 165K 156K 142K 18.1M 267K 1.84M 715K 9.25M 719K 704K 30.4M 211K 152K 131K 124K 113K 14.39M 212K 1.47M 569K 7.36M 572K 559K 24.16M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
  1. Stock Market
  2. Stocks
  3. OVAT Stock